Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
The potential contribution of satellite cells in spinal muscular atrophy skeletal muscles
EF 2013-14
Résumé
Spinal muscular atrophy (SMA) is a genetic disorder highlighted by the loss of nervous system cells in the spinal cord and muscle shrinkage, which ultimately leads to death in children. The incidence rate of SMA is 1 in 10,000. SMA patients and physicians focus on disease management rather than curing SMA as there is no effective medical treatment available (Oskoui and Kaufmann, 2008). Although SMA is primarily a motor neuron disease, the involvement of muscles in the disease has not been entirely ruled out. Preliminary data from Dr. Kothary’s laboratory demonstrates deregulation of a protein involved in maintaining muscle stem cells functioning called Pax7. Moreover, our group has observed altered muscle stem cell number in multiple mouse models of SMA. Muscle stem cells contribute to muscle growth following birth and we wondered whether mouse models of SMA have small muscles due to poor stem cell functioning. Thus, I hypothesize that the remaining stem cells present in muscles of mouse models of SMA do not function properly and do not efficiently contribute to postnatal muscle growth. In this project, I will first assess the efficacy of SMA muscle stem cells to form muscles. Then, I will investigate the ability of SMA stem cells to self-renew and to contribute to muscle healing. Taken together, this study will allow for a better understanding of whether muscle stem cell function is perturbed and in turn inform us whether this contributes to decrease muscle mass in SMA mice. Ultimately, the results of this project will shed light on muscle defects in mouse models of SMA should open up new therapeutic avenues for SMA.
References:
Oskoui, M. and Kaufmann P. (2008). Neurotherapeutics 5(4): 499-506.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
311850
Name
Deguise Marc-Olivier
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The potential contribution of satellite cells in spinal muscular atrophy skeletal muscles
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Transplantation; Immunohistochemistry; Mouse Model; Myogenesis; Satellite Cell; Skeletal Muscle Development; Spinal Muscular Atrophy
Abstract
Spinal muscular atrophy (SMA) is a genetic disorder highlighted by the loss of nervous system cells in the spinal cord and muscle shrinkage, which ultimately leads to death in children. The incidence rate of SMA is 1 in 10,000. SMA patients and physicians focus on disease management rather than curing SMA as there is no effective medical treatment available (Oskoui and Kaufmann, 2008). Although SMA is primarily a motor neuron disease, the involvement of muscles in the disease has not been entirely ruled out. Preliminary data from Dr. Kothary’s laboratory demonstrates deregulation of a protein involved in maintaining muscle stem cells functioning called Pax7. Moreover, our group has observed altered muscle stem cell number in multiple mouse models of SMA. Muscle stem cells contribute to muscle growth following birth and we wondered whether mouse models of SMA have small muscles due to poor stem cell functioning. Thus, I hypothesize that the remaining stem cells present in muscles of mouse models of SMA do not function properly and do not efficiently contribute to postnatal muscle growth. In this project, I will first assess the efficacy of SMA muscle stem cells to form muscles. Then, I will investigate the ability of SMA stem cells to self-renew and to contribute to muscle healing. Taken together, this study will allow for a better understanding of whether muscle stem cell function is perturbed and in turn inform us whether this contributes to decrease muscle mass in SMA mice. Ultimately, the results of this project will shed light on muscle defects in mouse models of SMA should open up new therapeutic avenues for SMA.
References:
Oskoui, M. and Kaufmann P. (2008). Neurotherapeutics 5(4): 499-506.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Deguise, Marc-Olivier
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~